Home › Quitting Smoking › NCT07489443
Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum
Partnering With Pregnant and Postpartum People to Co-Create a Novel Intervention to Reduce Tobacco and Cannabis Use
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Confirmed pregnant * Under 26 weeks gestation * Plan to remain pregnant * English speaking * Use of combustible tobacco at least once a week during pregnancy, or at least once a week in the 3 months before pregnancy if stopped * Use of cannabis at any frequency during pregnancy or in the 3 months before pregnancy if stopped Exclusion Criteria: * Current opioid use or active treatment for Opioid Use Disorder * Unable to provide informed consent in English * Under 18 years old
About the study
Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cannabis during pregnancy and stay quit postpartum.
What is being tested
- Perinatal smoking cessation treatment and maintenance sessions (behavioral)
Sponsor: University of Pittsburgh · Participants: 25 · Started: Jun 17, 2026
Contact the study team
- Project Coordinator · Phone: 412-301-3848
Official record on ClinicalTrials.gov — NCT07489443
Locations in the U.S.
| Pennsylvania | Bellefield Towers, Pittsburgh |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.